financetom
Business
financetom
/
Business
/
YouTube brings cheaper subscription tier to US with no ads, except for music
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
YouTube brings cheaper subscription tier to US with no ads, except for music
Mar 5, 2025 7:13 AM

SAN FRANCISCO (Reuters) - Alphabet's YouTube on Wednesday rolled out a $7.99 monthly subscription service that is ad-free for most videos, except music, to create a plan to compete more directly with offerings from Netflix and Disney.

The "Premium Lite" plan is aimed at customers who rarely watch music videos or listen to music. YouTube is a major player in the streaming music world, but the online video company has a substantial number of watchers who rarely use that function and may gravitate to the new service.

YouTube's existing $13.99 Premium plan has no ads, including for music, while a separate $10.99 plan offers ad-free music videos and other videos with ads, essentially the reverse of the new plan.

The new option fills a demand YouTube has been noticing for several years among users who already pay for other music streaming subscriptions. That dynamic is particularly apparent in the United States, where the market is led by Spotify and streaming offerings from Apple ( AAPL ) and Amazon.

John Harding, a vice president of engineering, said the main focus of the new plan is to tap into a "much larger set of people" who otherwise might not consider paying for YouTube. 

"We didn't feel that we really got it matching the tier for users that don't need the music content, and so that's where this revision comes in," said Jack Greenberg, the product director for YouTube Premium.

The company began testing Premium Lite last year in Australia, Germany and Thailand. The preliminary data showed a new user base of first-time subscribers paying for Premium Lite, Harding said, with some later upgrading to Premium. More people upgraded than the amount downgrading to the cheaper plan.

YouTube announced Wednesday that it had eclipsed 125 million paying subscribers, up from 100 million in January 2024, though those figures include users who are signed up for temporary free trials.

Ads comprise the majority of YouTube's revenue, accounting for $36 billion of Alphabet's $350 billion in overall 2024 revenue. But subscriptions are increasingly contributing to sales.

Alphabet is secretive about sharing YouTube's subscription-based revenue, but CEO Sundar Pichai stated during an October call about the company's third-quarter results that YouTube's combined ad and subscription revenue surpassed $50 billion over the previous four quarters.

Chief business officer Philipp Schindler also stated last year that subscriptions were boosting the bottom line for both YouTube and its content creators.

Some details regarding the U.S. launch of Premium Lite were first reported by Bloomberg in February.

YouTube in 2023 hiked the price of Premium and Music Premium by $2 and $1, respectively.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bristol Myers Squibb Validates Net-Zero Goals through Science Based Targets Initiative
Bristol Myers Squibb Validates Net-Zero Goals through Science Based Targets Initiative
Jul 18, 2024
10:55 AM EDT, 07/18/2024 (MT Newswires) -- Bristol Myers Squibb ( BMY ) said Thursday it has validated its near-term and longer-term targets to lower greenhouse emissions throughout its value chain to net-zero by 2050 through the Science Based Targets initiative. The drug maker announced its net-zero goal last year and also set several interim targets, including reducing its direct...
Ionis Pharmaceuticals Completes Trial Enrollment for Alexander Disease Treatment
Ionis Pharmaceuticals Completes Trial Enrollment for Alexander Disease Treatment
Jul 18, 2024
10:54 AM EDT, 07/18/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) said Thursday it completed enrollment in a clinical trial of zilganersen, an investigational ribonucleic acid-targeted medicine to treat children and adults with Alexander disease, a neurological disorder. Topline data are expected in H2 2025. The study is the first trial to evaluate an investigational medicine designed to address...
Volcon Regains Compliance With Nasdaq's Listing Requirements -- Shares Rise
Volcon Regains Compliance With Nasdaq's Listing Requirements -- Shares Rise
Jul 18, 2024
10:55 AM EDT, 07/18/2024 (MT Newswires) -- Volcon ( VLCN ) said Thursday it has been informed by Nasdaq that it has regained compliance with the stock exchange's listing rules. The company's shares were nearly 7% higher in recent trading. Price: 3.25, Change: +0.18, Percent Change: +5.70 ...
Why Siyata Mobile (SYTA) Stock Is Exploding Higher
Why Siyata Mobile (SYTA) Stock Is Exploding Higher
Jul 18, 2024
Siyata Mobile Inc ( SYTA ) shares are trading higher by 4.5% to $0.71 during Thursday’s session after the company announced new orders for its SD7 handsets and related accessories valued at more than $4.5 million in aggregate for US wireless carriers. CEO Marc Seelenfreund expects record sales in the third quarter of 2024, citing strong distribution channels and increasing adoption of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved